Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,62 USD | -1,50% | +1,55% | +73,51% |
17/04 | NUVATION BIO INC. : RBC Capital Markets geeft koopadvies | ZM |
10/04 | Nuvation Bio rondt overname van AnHeart Therapeutics af | MT |
Omzet 2024 * | - | Omzet 2025 * | 825K 768K | Marktkapitalisatie | 688 mln. 640 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -101 mln. -93,96 mln. | Nettowinst (verlies) 2025 * | -163 mln. -152 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 834 x |
K/w-verhouding 2024 * |
-7,42
x | K/w-verhouding 2025 * |
-5,21
x | Werknemers | 51 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,17% |
1 dag | -1,50% | ||
1 week | +1,55% | ||
Lopende maand | -28,02% | ||
1 maand | +16,44% | ||
3 maanden | +53,22% | ||
6 maanden | +127,83% | ||
Lopend jaar | +73,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Hung
FOU | Founder | 66 | 20-03-18 |
Moses Makunje
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Dong Fang Liu
CTO | Chief Tech/Sci/R&D Officer | 54 | 18-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hung
FOU | Founder | 66 | 20-03-18 |
Kim Blickenstaff
BRD | Director/Board Member | 71 | 01-08-19 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 01-10-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.03% | 0 M€ | 0,00% | - | |
0.02% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 2,62 | -1,50% | 642 571 |
24-04-24 | 2,66 | -0,75% | 1 280 789 |
23-04-24 | 2,68 | 0,00% | 885 607 |
22-04-24 | 2,68 | +3,08% | 1 086 344 |
19-04-24 | 2,6 | +0,78% | 1 666 802 |
uitgestelde koers Nyse, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+73,51% | 688 mln. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,07% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |